Document Detail

Role of statin therapy in the coronary bypass patient.
MedLine Citation:
PMID:  15276569     Owner:  NLM     Status:  MEDLINE    
Statins have been proven to prevent or delay ischemic events in patients at risk for atherosclerotic coronary disease. Increasing evidence suggests that statin therapy is also beneficial to patients undergoing coronary revascularization. In this review statin therapy will be shown to improve vein graft patency, minimize recurrent ischemic events, and decrease the need for repeat revascularization procedures in patients who have undergone coronary artery bypass grafting.
Harold L Lazar
Related Documents :
8772679 - Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis....
13130409 - Association between protease inhibitor use and increased cardiovascular risk in patient...
16428899 - Statins decrease serotonin-induced contractions in coronary arteries of swine in vitro.
15172899 - Association of statin therapy with outcomes of acute coronary syndromes: the grace study.
15922259 - Statin mediated protection of the ischemic myocardium.
16386629 - Safety of statins when response is carefully monitored: a study of 336 heart recipients.
21096749 - Textile-templated electrospun anisotropic scaffolds for tissue engineering and regenera...
1991669 - Transcardiac alteration of neutrophil function before and after coronary thrombolysis i...
19443469 - Atrial reservoir function by strain rate imaging in asymptomatic mitral stenosis: progn...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  78     ISSN:  1552-6259     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2004 Aug 
Date Detail:
Created Date:  2004-07-27     Completed Date:  2005-05-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  730-40     Citation Subset:  AIM; IM    
Department of Cardiothoracic Surgery, Boston University School of Medicine and the Boston Medical Center, 88 E. Newton Street, B404, Boston, MA 02118, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Cholesterol, LDL / blood
Clinical Trials as Topic
Coronary Artery Bypass*
Coronary Artery Disease / drug therapy,  etiology,  surgery
Coronary Restenosis / prevention & control*
Endothelium, Vascular / physiopathology
Follow-Up Studies
Heart Transplantation
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / complications,  drug therapy*
Myocardial Ischemia / drug therapy
Physician's Role
Postoperative Complications / prevention & control
Stroke / prevention & control
Reg. No./Substance:
0/Cholesterol, LDL; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Total extracardiac cavopulmonary connection: an alternative technique of fenestration.
Next Document:  First robotic endoscopic epicardial isolation of the pulmonary veins with microwave energy in a pati...